Formulary guidance and transparency from P&T to point of care

MMIT Reality Check on Heart Failure (Nov 2017)

Posted by Matt Breese on Nov 7, 2017

Find me on:

According to our recent payer coverage analysis for chronic heart failure treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Payer Coverage: A look at market access over the past two quarters shows a continued relaxation in formulary coverage across commercial and medicare formularies. PAs and step edit policies remained relatively unchanged.

mmit-reality-check-chronic heart failure-q42017.png

Source: MMIT data as of Q2 2017

Trends:  A few major prescribing trends include an increased focus on standard treatment paths encouraged by specialty societies like the American College of Cardiology. Additional technological advancements are expected to shift prescribing habits.

To read the full Reality Check on Heart Failure with key findings on clinical characteristics, acne drug market access and payer coverage, please click on the button below: 


View Reality Check

Topics: Specialty, Market Access, Payer, Branding & Marketing